Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
1. Schembl24175
2. Chembl1201175
3. Dtxsid20979825
4. Akos015894824
Molecular Weight | 432.77 g/mol |
---|---|
Molecular Formula | C15H17ClN4O9 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 7 |
Exact Mass | 432.0684058 g/mol |
Monoisotopic Mass | 432.0684058 g/mol |
Topological Polar Surface Area | 243 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 543 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Alomide |
PubMed Health | Lodoxamide (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | ALOMIDE (lodoxamide tromethamine ophthalmic solution) 0.1% is a sterile ophthalmic solution containing the mast cell stabilizer lodoxamide tromethamine for topical administration to the eyes. Lodoxamide tromethamine is a white, crystalline, water-s... |
Active Ingredient | Lodoxamide tromethamine |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.1% base |
Market Status | Prescription |
Company | Alcon |
2 of 2 | |
---|---|
Drug Name | Alomide |
PubMed Health | Lodoxamide (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | ALOMIDE (lodoxamide tromethamine ophthalmic solution) 0.1% is a sterile ophthalmic solution containing the mast cell stabilizer lodoxamide tromethamine for topical administration to the eyes. Lodoxamide tromethamine is a white, crystalline, water-s... |
Active Ingredient | Lodoxamide tromethamine |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | eq 0.1% base |
Market Status | Prescription |
Company | Alcon |
Regulatory Info :
Registration Country : Italy
Brand Name : Alomide
Dosage Form :
Dosage Strength : 20 Monod Coll 0.5 Ml 0.1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Alomide
Dosage Form :
Dosage Strength : Coll 5 Ml 0.1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
A Lodoxamide Tromethamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lodoxamide Tromethamine, including repackagers and relabelers. The FDA regulates Lodoxamide Tromethamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lodoxamide Tromethamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lodoxamide Tromethamine supplier is an individual or a company that provides Lodoxamide Tromethamine active pharmaceutical ingredient (API) or Lodoxamide Tromethamine finished formulations upon request. The Lodoxamide Tromethamine suppliers may include Lodoxamide Tromethamine API manufacturers, exporters, distributors and traders.
Lodoxamide Tromethamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lodoxamide Tromethamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lodoxamide Tromethamine GMP manufacturer or Lodoxamide Tromethamine GMP API supplier for your needs.
A Lodoxamide Tromethamine CoA (Certificate of Analysis) is a formal document that attests to Lodoxamide Tromethamine's compliance with Lodoxamide Tromethamine specifications and serves as a tool for batch-level quality control.
Lodoxamide Tromethamine CoA mostly includes findings from lab analyses of a specific batch. For each Lodoxamide Tromethamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lodoxamide Tromethamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Lodoxamide Tromethamine EP), Lodoxamide Tromethamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lodoxamide Tromethamine USP).
LOOKING FOR A SUPPLIER?